GTCM
HAE icon

Gyon Technologies Capital Management’s Haemonetics HAE Stock Holding History

Gyon Technologies Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13,067
Closed -$922K – 593
2021
Q3 		$922K Buy
+13,067
New +$825K 0.25% 126
2021
Q2 		– Sell
-4,820
Closed -$535K – 415
2021
Q1 		$535K Sell
4,820
-1,312
-21% -$162K 0.23% 147
2020
Q4 		$728K Buy
+6,132
New +$660K 0.25% 126

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Gyon Technologies Capital Management's HAE Position: Q4 2021 in Review

Gyon Technologies Capital Management sold out of Haemonetics (HAE) in Q4 2021, closing a stake of 13,067 shares — an estimated $922K sold.

Gyon Technologies Capital Management first reported a position in HAE in Q4 2020 and held it in 3 quarters. The position peaked at $922K in Q3 2021. 257 funds tracked by Wall St. Rank hold HAE as of Q4 2021.

  • Gyon Technologies Capital Management reported no remaining Haemonetics position as of Q4 2021 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 13,067 Haemonetics shares in Q4 2021, an estimated $922K.
  • Gyon Technologies Capital Management first reported a position in Haemonetics in Q4 2020 and held it in 3 quarters.
  • Gyon Technologies Capital Management's Haemonetics position peaked at $922K in Q3 2021.
  • 257 funds tracked by Wall St. Rank held Haemonetics as of Q4 2021.

Based on Gyon Technologies Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.